Subscribe Become an Author Sign Up Log In

Clinical Trial Supply New England 2020

   by BiopharmaTrend    90    Comments 0

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Following on from another successful conference Arena International will be returning with full force to Waltham in March to celebrate another edition of the Clinical Trial Supply show.

The event is a 2-day B2B conference bringing together trial sponsors and key stakeholders with industry vendors. We aim to offer case studies and insights into how to effectively manage operational issues across the clinical trial supply china.

2020 will gather the key stakeholders in the clinical trials community, including the FDA, US Customs and Border Protection, Biogen, Sanofi, Blueprint Medicines Corporation along with small to large pharmas. With interactive session formats, fresh content and networking, the event will provide attendees with an unparalleled opportunity for collaboration between players across the whole industry.

Arena International strives on convening the perfect attendees at every event, that is why Clinical Trial Supply North East will benefit from having over 200+ attendees, of which 65% are at Director+ level, 25+ speakers and 30+ exhibitors.

Join us on 24-25 March 2020 at The Westin Waltham in Waltham, Massachusetts to experience this unique platform for clinical trial sponsors and solution providers. PRIORITY REGISTRATION is now open, use priority code: KL-KL https://arena-international.com/ctsnewengland/register/.

Follow us on Twitter @ArenaIntCTS

LinkedIn https://www.linkedin.com/groups/8414794/

We look forward to seeing you there!

Share this:              

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *